Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laquinimod Extension Study in RRMS
NCT00745615Phase 2Terminated
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2005
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of laquinimod in multiple sclerosis (MS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2005; status: terminated.
02
Drugs
laquinimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT00745615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00745615.